Skip to main content

Table 4 Subgroup analysis for the incidence of overall complications

From: Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis

 

No. studies

Samples

OR

95% CI

P value

I2

Measurement method

 SMI

3

380

1.29

0.82–2.03

0.27

0%

 PMI

3

1483

1.34

0.62–2.87

0.45

75%

Region of studies

 Asia

3

587

1.10

0.66–1.86

0.71

43%

 Non-Asia

3

1276

1.49

0.69–3.23

0.31

86%

  1. SMI Skeletal mass index, PMI Psoas mass index, OR Odds ratio, CI Corresponding intervals